VCU Massey Cancer Center


Massey member directory

For members: update your profile »

« Back to member list

Gordon D. Ginder, M.D.

Massey Cancer Center research program membership

Cancer Molecular Genetics

Department affiliations

Professor and Eminent Scholar, Department of Human and Molecular Genetics, School of Medicine
Professor and Eminent Scholar, Department of Microbiology and Immunology, School of Medicine
Professor and Eminent Scholar, Division of Hematology-Oncology and Palliative Care, Department of Internal Medicine, School of Medicine

Endowed and distinguished chair or professorship

Jeanette and Eric Lipman Chair in Oncology


MD, Johns Hopkins University (1975)

Awards and honors

Virginia's Outstanding Scientist of the Year, 2003, The Governor of Virginia
W. Robert Irby Award for Philanthropic Leadership, 2002, The MCV Foundation

Research description

My research focuses on epigenetic control of gene expression during hematopoietic cell differentiation and in hematopoietic and solid tumor malignancies. My main research projects currently involve understanding the mechanisms through which the MBD2-NuRD and MBD3 -NuRD chromatin remodeling complexes control gene expression during erythroid cell differentiation and in acute leukemia. Through a combination of structural and functional studies, the goal is to identify protein protein interactions in the NuRD complex that can be targeted to achieve therapeutic effects in hereditary anemias, such as sickle cell anemia, thalassemia, and acute leukemia. The same NuRD complex mediates both suppression of fetal globin gene expression and leukemia cell clonogenicity and resistance to genotoxic chemotherapy. Findings to date show that depletion of the same critical NuRD components or mutation of the same critical protein-protein interactions leads to derepression of fetal globin gene expression in adult erythroid cells and increased genotoxic sensitivity and decreased clonogenicity of acute leukemia cells. The objective is the development of small molecule therapeutics to target NuRD in hereditary anemias and acute leukemia and other malignancies.

Disease focus of research

Hematologic Malignancies

Research keywords

Apoptosis,Cancer cell biology,Cancer therapy resistance,Cancer therapy toxicities,DNA damage,Epigenetics,Molecular medicine,Precision medicine,Targeted therapies,Translational science

Published research (during tenure as a Massey Cancer Center member)

Search In PubMed

Contact information


View graphic version